RxDoctor Payments Data

Ana Tergas, MD

Obstetrics & Gynecology · Duarte, CANPI 1326346065

Payments from drug & device makers

What this record shows

This record is dominated by grants: $100,000 of the $114,884 with a category attached, or 87.0%. Sanofi accounts for 87.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $57,800 and has fallen 88.1% since, to $6,894 in 2024. Among obstetrics & gynecology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$114,884in general payments, 2019–2025

Across 29 payments — averaging $3961.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$100K
  • Merck$8K
  • GSK$7K
  • Kyowa Kirin, Inc.$47
  • Tesaro, Inc.$45
  • Clovis Oncology, Inc.$21
  • plus $70 from 4 others
$56,541in research payments, 2019–2025

Across 10 payments — averaging $5654.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$57K

What the payments were for

  • Consulting fees$12,14811%
  • Grants$100,00087%
  • Travel & lodging$2,0612%
  • Food & beverage$6641%
  • Education$110%

General payments by program year

19
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi2$100,000
Merck12$7,826
GSK7$6,875
Kyowa Kirin, Inc.2$47
Tesaro, Inc.1$45
Clovis Oncology, Inc.1$21
Foundation Medicine, Inc.1$20
AbbVie1$19
Pfizer1$18
Amgen1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$114,884 in reported general payments places this provider in the 95th percentile of 3,784 obstetrics & gynecology providers in California.

See all obstetrics & gynecology providers in California

Medicare billing

Part B allowed, 2024
$9,054
Medicare patients
36
Services billed
74

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other obstetrics & gynecology in Duarte

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →